Annals of Hematology

, 88:907

Surveillance with successful reduction of central line-associated bloodstream infections among neutropenic patients with hematologic or oncologic malignancies

  • Iris F. Chaberny
  • Evelina Ruseva
  • Dorit Sohr
  • Stefanie Buchholz
  • Arnold Ganser
  • Frauke Mattner
  • Petra Gastmeier
Original Article
  • 291 Downloads

Abstract

To determine nosocomial catheter-associated bloodstream infections (CA-BSIs) and to improve the prevention measures, we performed a prospective surveillance in our hematopoietic stem cell transplantation unit at our university hospital. During the 36-month study period all patients with at least two consecutive neutropenic days (NDs) were included. After the first 18 months the recorded data were analyzed and compared with reference data and were then presented to the clinical staff. An intensive training to improve the handling of central venous lines was performed afterwards. At the end of the last 18-month study period the data were evaluated and a multivariate analysis was conducted. Altogether 268 patients were treated for a period of 10,013 patient days including 4,286 NDs. A total of 202/268 (75.4%) patients underwent transplantation (157/76.6% allogeneic, 48/23.4% autologous). Eighty-seven CA-BSIs were identified. The incidence density was 24.3 CA-BSI episodes per 1,000 NDs in the first period and 16.2 in the second. A significant reduction in the CA-BSI rate of adults was achieved (OR 0.58; 95% CI 0.339–0.987; p < 0.05). Significant risk factors for nosocomial CA-BSIs during the neutropenic phase were AML as underlying disease as well as transplantations.

Keywords

Surveillance Neutropenia Nosocomial Bloodstream infection 

References

  1. 1.
    Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598–1601. doi:10.1001/jama.271.20.1598 PubMedCrossRefGoogle Scholar
  2. 2.
    Laupland KB, Lee H, Gregson DB, Manns BJ (2006) Cost of intensive care unit-acquired bloodstream infections. J Hosp Infect 63:124–132. doi:10.1016/j.jhin.2005.12.016 PubMedCrossRefGoogle Scholar
  3. 3.
    Higuera F, Rangel-Frausto MS, Rosenthal VD, Soto JM, Castanon J, Franco G, Tabal-Galan N, Ruiz J, Duarte P, Graves N (2007) Attributable cost and length of stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol 28:31–35. doi:10.1086/510812 PubMedCrossRefGoogle Scholar
  4. 4.
    Busca A, Saroglia EM, Giacchino M, Vai S, Vassallo E, Fagioli F, Linari A, Dotti G, Miniero R, Madon E (1999) Analysis of early infectious complications in pediatric patients undergoing bone marrow transplantation. Support Care Cancer 7:253–259. doi:10.1007/s005200050257 PubMedCrossRefGoogle Scholar
  5. 5.
    Elishoov H, Or R, Strauss N, Engelhard D (1998) Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study. Medicine (Baltimore) 77:83–101. doi:10.1097/00005792-199803000-00002 CrossRefGoogle Scholar
  6. 6.
    Carlisle PS, Gucalp R, Wiernik PH (1993) Nosocomial infections in neutropenic cancer patients. Infect Control Hosp Epidemiol 14:320–324PubMedGoogle Scholar
  7. 7.
    Ashkenazi S, Leibovici L, Samra Z, Konisberger H, Drucker M (1992) Risk factors for mortality due to bacteremia and fungemia in childhood. Clin Infect Dis 14:949–951PubMedGoogle Scholar
  8. 8.
    Guven GS, Uzun O, Cakir B, Akova M, Unal S (2006) Infectious complications in patients with hematological malignancies consulted by the infectious diseases team: a retrospective cohort study (1997–2001). Support Care Cancer 14:52–55. doi:10.1007/s00520-005-0836-1 PubMedCrossRefGoogle Scholar
  9. 9.
    CDC (2000) Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of the Centers for Disease Control and Prevention, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Recomm Rep 49:1–125Google Scholar
  10. 10.
    Dettenkofer M, Wenzler-Rottele S, Babikir R, Bertz H, Ebner W, Meyer E, Ruden H, Gastmeier P, Daschner FD (2005) Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project. Clin Infect Dis 40:926–931. doi:10.1086/428046 PubMedCrossRefGoogle Scholar
  11. 11.
    Gaynes RP, Horan TC (1999) Surveillance of nosocomial infections. Appendix A: CDC definitions of nosocomial infections. In: Mayhall CG (ed) Hospital epidemiology and infection control. 2nd edn. Lippincott, Williams & Wilkins, Philadelphia, pp 1296–1307Google Scholar
  12. 12.
    O’Grady N, Alexander M, Patchen Dellinger E, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA (2002) Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 51:1–32PubMedGoogle Scholar
  13. 13.
    \Anonymous (2002) Prevention of vascular catheter-associated infections. Bundesgesundheitsbl 45:907–924. doi:10.1007/s00103-002-0499-8 CrossRefGoogle Scholar
  14. 14.
    Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C (2006) An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355:2725–2732. doi:10.1056/NEJMoa061115 PubMedCrossRefGoogle Scholar
  15. 15.
    Bijma R, Girbes AR, Kleijer DJ, Zwaveling JH (1999) Preventing central venous catheter-related infection in a surgical intensive-care unit. Infect Control Hosp Epidemiol 20:618–620. doi:10.1086/501682 PubMedCrossRefGoogle Scholar
  16. 16.
    Bishop-Kurylo D (1998) The clinical experience of continuous quality improvement in the neonatal intensive care unit. J Perinat Neonatal Nurs 12:51–57PubMedGoogle Scholar
  17. 17.
    Civetta JM, Hudson-Civetta J, Ball S (1996) Decreasing catheter-related infection and hospital costs by continuous quality improvement. Crit Care Med 24:1660–1665. doi:10.1097/00003246-199610000-00010 PubMedCrossRefGoogle Scholar
  18. 18.
    Cohran J, Larson E, Roach H, Blane C, Pierce P (1996) Effect of intravascular surveillance and education program on rates of nosocomial bloodstream infections. Heart Lung 25:161–164. doi:10.1016/S0147-9563(96)80120-8 PubMedCrossRefGoogle Scholar
  19. 19.
    Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D (2000) Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 355:1864–1868. doi:10.1016/S0140-6736(00)02291-1 PubMedCrossRefGoogle Scholar
  20. 20.
    Maas A, Flament P, Pardou A, Deplano A, Dramaix M, Struelens MJ (1998) Central venous catheter-related bacteraemia in critically ill neonates: risk factors and impact of a prevention programme. J Hosp Infect 40:211–224. doi:10.1016/S0195-6701(98)90139-6 PubMedCrossRefGoogle Scholar
  21. 21.
    Yoo S, Ha M, Choi D, Pai H (2001) Effectiveness of surveillance of central catheter-related bloodstream infection in an ICU in Korea. Infect Control Hosp Epidemiol 22:433–436. doi:10.1086/501930 PubMedCrossRefGoogle Scholar
  22. 22.
    Warren DK, Zack JE, Mayfield JL, Chen A, Prentice D, Fraser VJ, Kollef MH (2004) The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 126:1612–1618. doi:10.1378/chest.126.5.1612 PubMedCrossRefGoogle Scholar
  23. 23.
    CDC (2005) Centers for disease control and prevention: reduction in central line-associated bloodstream infections among patients in intensive care units—Pennsylvania, April 2001–March 2005. MMWR 54:1013–1016Google Scholar
  24. 24.
    Berenholtz SM, Pronovost PJ, Lipsett PA, Hobson D, Earsing K, Farley JE, Milanovich S, Garrett-Mayer E, Winters BD, Rubin HR, Dorman T, Perl TM (2004) Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 32:2014–2020. doi:10.1097/01.CCM.0000142399.70913.2F PubMedCrossRefGoogle Scholar
  25. 25.
    Cordonnier C, Buzyn A, Leverger G, Herbrecht R, Hunault M, Leclercq R, Bastuji-Garin S (2003) Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis 36:149–158. doi:10.1086/345435 PubMedCrossRefGoogle Scholar
  26. 26.
    Pizzo PA (1999) Fever in immunocompromised patients. N Engl J Med 341:893–900. doi:10.1056/NEJM199909163411207 PubMedCrossRefGoogle Scholar
  27. 27.
    Santolaya ME, Alvarez AM, Aviles CL, Becker A, Cofre J, Enriquez N, O’Ryan M, Paya E, Salgado C, Silva P, Tordecilla J, Varas M, Villarroel M, Viviani T, Zubieta M (2002) Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis 35:678–683. doi:10.1086/342064 PubMedCrossRefGoogle Scholar
  28. 28.
    Meyer E, Beyersmann J, Bertz H, Wenzler-Rottele S, Babikir R, Schumacher M, Daschner FD, Ruden H, Dettenkofer M (2007) Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation. Bone Marrow Transplant 39:173–178. doi:10.1038/sj.bmt.1705561 PubMedCrossRefGoogle Scholar
  29. 29.
    Dettenkofer M, Ebner W, Bertz H, Babikir R, Finke J, Frank U, Ruden H, Daschner FD (2003) Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant 31:795–801. doi:10.1038/sj.bmt.1703920 PubMedCrossRefGoogle Scholar
  30. 30.
    Niel-Weise BS, Stijnen T, van den Broek PJ (2008) Anti-infective-treated central venous catheters for total parenteral nutrition or chemotherapy: a systematic review. J Hosp Infect 69:114–123. doi:10.1016/j.jhin.2008.02.020 PubMedCrossRefGoogle Scholar
  31. 31.
    Logghe C, Van Ossel C, D’Hoore W, Ezzedine H, Wauters G, Haxhe JJ (1997) Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect 37:145–156. doi:10.1016/S0195-6701(97)90184-5 PubMedCrossRefGoogle Scholar
  32. 32.
    Gastmeier P, Geffers C (2006) Prevention of catheter-related bloodstream infections: analysis of studies published between 2002 and 2005. J Hosp Infect 64:326–335. doi:10.1016/j.jhin.2006.07.005 PubMedCrossRefGoogle Scholar
  33. 33.
    Richards C, Emori TG, Peavy G, Gaynes R (2001) Promoting quality through measurement of performance and response: prevention success stories. Emerg Infect Dis 7:299–301PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Iris F. Chaberny
    • 1
  • Evelina Ruseva
    • 1
  • Dorit Sohr
    • 2
  • Stefanie Buchholz
    • 3
  • Arnold Ganser
    • 3
  • Frauke Mattner
    • 1
  • Petra Gastmeier
    • 1
  1. 1.Institute of Medical Microbiology and Hospital EpidemiologyHannover Medical SchoolHannoverGermany
  2. 2.Institute of Hygiene and Environmental MedicineCharité-University Medicine BerlinBerlinGermany
  3. 3.Department of Hematology, Hemostasis, Oncology and Stem Cell TransplantationHannover Medical SchoolHannoverGermany

Personalised recommendations